Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-12-195306
Filing Date
2012-04-30
Accepted
2012-04-30 14:22:43
Documents
5
Effectiveness Date
2012-04-30

Document Format Files

Seq Description Document Type Size
1 DEFA14A d336720ddefa14a.htm DEFA14A 31990
2 GRAPHIC g336720img1.jpg GRAPHIC 35673
3 GRAPHIC g336720img2.jpg GRAPHIC 14362
4 GRAPHIC g336720img3.jpg GRAPHIC 1673
5 GRAPHIC g336720img4.jpg GRAPHIC 2498
  Complete submission text file 0001193125-12-195306.txt   108548
Mailing Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034
Business Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33958 | Film No.: 12794050
SIC: 2834 Pharmaceutical Preparations